PMID: 11311508Apr 20, 2001Paper

Post-training injections of catecholaminergic drugs do not modulate fear conditioning in rats and mice

Neuroscience Letters
H J LeeJ J Kim

Abstract

Studies employing classical fear conditioning (FC) and inhibitory avoidance (IA), two procedurally different aversive tasks, provide different insight into the neuronal mechanism(s) underlying fear learning. We examined whether immediate post-training injections of catecholaminergic drugs modulate memory consolidation in one-trial FC, as has been demonstrated in one-trial IA. Neither epinephrine (0.1, 0.3, 1.0 mg/kg intraperitoneally) nor amphetamine (1.0, 2.0 mg/kg) modulates FC to tone or context, as indicated by freezing in rats. Similarly, epinephrine (0.1, 1.0 mg/kg) and beta-adrenergic antagonists (sotalol and propranolol; 2 mg/kg) also failed to modulate FC in mice. These results indicate that FC is not susceptible to memory modulation by catecholaminergic drugs in the manner described in IA tasks.

References

May 1, 1986·Behavioral and Neural Biology·I B Introini-Collison, J L McGaugh
May 1, 1994·Trends in Neurosciences·M DavisM Cassell
Feb 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·B RoozendaalJ L McGaugh
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·J L McGaughB Roozendaal
Jul 7, 1999·Neuroscience and Biobehavioral Reviews·M Fendt, M S Fanselow
Jan 14, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S G AnagnostarasM S Fanselow
Jan 15, 2000·Science·J L McGaugh
Jun 9, 2000·Annual Review of Neuroscience·J E LeDoux

❮ Previous
Next ❯

Citations

Mar 10, 2004·Psychopharmacology·Christian GrillonMichael Davis
Jan 20, 2006·Behavioral Neuroscience·Richard W MorrisA S Killcross
Feb 28, 2002·The European Journal of Neuroscience·Brigitte SchulzHans-Ulrich Schnitzler
Nov 28, 2013·Proceedings of the National Academy of Sciences of the United States of America·Robert M SearsJoseph E Ledoux
Apr 30, 2009·Annual Review of Neuroscience·Sarina M RodriguesRobert M Sapolsky
Dec 10, 2014·Proceedings of the National Academy of Sciences of the United States of America·Joshua P JohansenJoseph E LeDoux
Mar 5, 2016·Psychopharmacology·Ester AlvesMónica Moreira-Rodrigues
Jul 14, 2010·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Guy KatzMichael Arad
Aug 8, 2006·Annals of the New York Academy of Sciences·Melinda M Miller, Bruce S McEwen
Aug 27, 2005·Neuroscience and Biobehavioral Reviews·Jeansok J Kim, Min Whan Jung
Dec 23, 2014·Neurobiology of Stress·Candace M Raio, Elizabeth A Phelps
Apr 7, 2004·Cell·Charles F MurchisonSteven A Thomas
Nov 1, 2011·Cell·Joshua P JohansenJoseph E LeDoux
Aug 11, 2004·Hippocampus·Paul W FranklandAlcino J Silva
Sep 18, 2018·Nature Human Behaviour·Joseph E DunsmoorElizabeth A Phelps
Nov 26, 2009·Plastic and Reconstructive Surgery·Julia K Terzis, Vasileios K Kostopoulos
Mar 30, 2018·Frontiers in Behavioral Neuroscience·Thomas F Giustino, Stephen Maren
Nov 17, 2020·Frontiers in Molecular Neuroscience·Raquel MartinhoMónica Moreira-Rodrigues

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.